05RS HB376

WWW Version
The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.

Includes opposite chamber sponsors where requested by primary sponsors of substantially similar bills in both chambers and jointly approved by the Committee on Committees of both chambers. Opposite chamber sponsors are represented in italics.

HB 376 (BR 1138) - J. Wayne, D. Floyd, M. Harmon, J. Higdon, S. Lee, D. Owens

AN ACT relating to a tax credit for investments in adult stem cell research.
Create a new section of KRS Chapter 141 to define "adult stem cell investment" as an investment in adult stem cell research and does not include human stem cell research from human embryos; allow a nonrefundable tax credit of 50% of the cost of an approved adult stem cell investment, subject to a $500,000 maximum per year, and a total of $3 million for all taxpayers in each calendar year; permit unused credit to be carried forward for 10 years; and amend KRS 141.0205 to list the adult stem cell investment credit to be taken against individual and corporate taxes.

Feb 9-introduced in House
Feb 10-to Appropriations and Revenue (H)

Kentucky Legislature Home Page | Record Front Page